Wellington Management Group LLP Centessa Pharmaceuticals PLC Transaction History

Wellington Management Group LLP

  • $551 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$3.18 - $9.85 $2.31 Million - $7.16 Million
-727,273 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$10.99 - $17.54 $7.99 Million - $12.8 Million
727,273 New
727,273 $8.19 Million
Q3 2021

Nov 15, 2021
SELL
$16.7 - $23.11 $18.5 Million - $25.6 Million
-1,106,577 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$21.71 - $25.66 $24 Million - $28.4 Million
1,106,577 New
1,106,577 $24.6 Million

Others Institutions Holding CNTA

# of Institutions
73
Shares Held
84.5M
Call Options Held
17.7K
Put Options Held
5K
View Full List

About Centessa Pharmaceuticals plc

CNTA Quotes by TradingView
  • Ticker CNTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,339,296
  • Market Cap $852M
  • Description
  • Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...
More about CNTA
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email